病毒感染Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the sotrovimab face but is escaped by Omicron.
期刊:iScience发表年份:2023作者:Jakob Kreye; S Momsen Reincke; Stefan Edelburg; Lara M Jeworowski; Hans-Christian Kornau; Jakob Trimpert; Peter Hombach; Sophia Halbe; Volker Nölle; Martin Meyer; Stefanie Kattenbach; Elisa Sánchez-Sendin; Marie L Schmidt; Tatjana Schwarz; Ruben Rose
